You are here

Article Text

Article menu
Download PDFPDF
LETTER
Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy
  1. P Bot1,
  2. B A Semmekrot1,
  3. J van der Stappen2
  1. 1Department of Paediatrics, Canisius-Wilhelmina Hospital, PO Box 9015, 6500 GS Nijmegen, the Netherlands
  2. 2Department of Clinical Chemical Analysis, Canisius-Wilhelmina Hospital
  1. Correspondence to:
    Dr Semmekrot
    B.Semmekrot{at}cwz.nl

https://doi.org/10.1136/adc.2004.066431

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Selective serotonin reuptake inhibitors (SSRIs) are often prescribed during pregnancy.

    It has long been debated whether adverse neonatal effects described after maternal SSRI use1–4 are caused by serotonin toxicity or withdrawal.5 Recently, the information of a database analysis of 93 suspected cases of SSRI induced neonatal withdrawal has been regarded as enough information to confirm a possible causal relation.6

    We describe six infants with neonatal symptoms …

    View Full Text

    Footnotes

    • Competing interests: none declared